ArticlePloS one2026
Impact of device sales representatives in the operating room on clinical outcomes during standard endovascular aneurysm repair: A retrospective case-control study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Device sales representatives (DSRs) play a key role in providing vascular surgeons with device-specific education, operational guidance, and troubleshooting support. However, industry relationships may introduce bias, raising ethical concerns. This study aimed to evaluate the clinical benefit of DSR presence in the operating room (OR) during standard, infrarenal endovascular aortic repair (EVAR). A retrospective, case-control study was conducted to assess the association between DSR presence and surgical outcomes in elective, infrarenal EVAR cases at an experienced endovascular institution. Preoperative (age, gender, ASA classification, and past medical history), perioperative (device company, OR and fluoroscopy time, and use of additional endografts or stents) and postoperative (length of hospital stay post-operation, endoleaks at six weeks and six months, and mortality at six months) variables were collected for cases between June 1st, 2019 to December 31st, 2022. Fisher's exact test, chi-squared test and student's t-test were used to compare DSR-present and control groups. Ninety standard infrarenal EVARs were included with a DSR present in 64 (71.1%) cases. Cook and Gore devices were used in roughly equal proportions with a single case using a Medtronic device. DSR presence was not associated with a statistically significant change in operative duration (p = 0.53) or fluoroscopy time (p = 0.95), or in rates of endograft usage (p = 0.35) or adjunctive stent use (p = 1.00). Length of hospital stay (p = 0.46), short- (p = 0.63) and long-term (p = 1.00) endoleaks, and mortality rates (p = 1.00) were similar between groups. In this study of standard, infrarenal EVAR procedures at a high volume endovascular centre, DSR presence was not associated with statistically significant differences in case efficiency, device utilization or clinical outcomes. These findings suggest that routine DSR involvement in such procedures may not provide a clear clinical advantage. In light of important ethical considerations, the study calls for a more selective use of DSR support and for larger, multicentre studies to better understand their role in EVAR cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.